Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse DCAMKL1 ELISA Kit (AC3398)
Cat.#: ASET-1987
Specifications
Description Mouse DCAMKL1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse DCAMKL1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 15.93 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 250-4000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1438 Human COLEC12 ELISA Kit (AC2849) Quantitative inquiry ASET-2042 Human Ephrin A4 ELISA Kit (AC3453) Quantitative inquiry ASET-1248 Rat Cathepsin G ELISA Kit (AC2659) Quantitative inquiry ASET-1634 Human Adenosine Receptor A2a ELISA Kit (AC3045) Quantitative inquiry ASET-1492 Human GABARAPL1 ELISA Kit (AC2903) Quantitative inquiry ASET-2051 Human Cx30 ELISA Kit (AC3462) Quantitative inquiry ASET-1514 Human Slit3 ELISA Kit (AC2925) Quantitative inquiry ASET-2504 Rat 160 kD Neurofilament Medium ELISA Kit (AC3915) Quantitative inquiry ASET-1682 Human Somatostatin ELISA Kit (AC3093) Quantitative inquiry ASET-1984 Mouse PGP9.5 ELISA Kit (AC3395) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket